Project Grant R35GM161597
- Federal Grant Award Summary Cornell University received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through April 30, 2028. The award supports fundamental research to decode inter-organelle phospholipid transport through innovative fluxome profiling methodology. The research will establish a comprehensive method to measure phospholipid transport in...
- Federal Project Grant Award Summary Cornell University received a $375,154 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with completion targeted for February 28, 2031. The award supports fundamental research to uncover the structure and function of understudied membrane proteins implicated in human diseases. The research employs Caenorhabditis elegans as a model...
- Federal Grant Award Summary Award Details: Cornell University's Office of Sponsored Programs received a $305,208 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award supports fundamental research into ubiquitin mechanisms in cellular health and pathogen-host interactions, a critical area of investigation given ubiquitination's central role...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $291,491 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. This award supports fundamental research to advance understanding of autolysin function in gram-negative bacterial growth and morphogenesis. The research focuses on elucidating the...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $856,404 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through May 31, 2030. The award funds fundamental research investigating the mechanisms of robustness in organogenesis, specifically how developing organs reliably achieve consistent size and shape despite...
- Federal Project Grant Award Summary Cornell University received a $380,785 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 15, 2025, with completion targeted for August 31, 2030. The award supports research on quantitative recovery of biomolecular structural ensembles from cryo-electron microscopy (cryo-EM), a technique that captures protein conformational states by...
- Federal Project Grant Award Summary Cornell University was awarded $380,262 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop theoretical and computational methods for investigating redox processes in biological systems. The project, initiated August 1, 2025, and concluding July 31, 2030, will deliver a simulation toolbox utilizing path integral quantum mechanics formulations to characterize electron...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $390,966 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through March 31, 2031. The award funds fundamental biomedical research investigating the epitranscriptome—the comprehensive profile of RNA modifications—and its role in tailoring gene expression systems across different organisms....
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $471,690 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026, with completion targeted for February 28, 2031. The award funds fundamental research to discover and elucidate the mechanisms of lipid scramblases—specialized proteins that catalyze the translocation of polar lipids across...
- Federal Project Grant Award Summary The University of Rochester received a $414,159 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. This award supports fundamental research investigating how eukaryotic cells employ differential stress response mechanisms to adapt to physiological challenges. The research focuses on understanding how cells...
Cornell University received a $404,864 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 22, 2026, with a completion date of March 31, 2031. The award supports fundamental research into quantitative membrane contact site biology in macroautophagy (autophagy)—an intracellular degradation process critical to cellular homeostasis and implicated in neurodegeneration, metabolic disease, and cancer. The research aims to develop mechanistic and quantitative understanding of autophagosome biogenesis, the formation of double-membrane organelles essential to cellular waste degradation and metabolite recycling. The funded research will produce scientific advances in understanding the committed regulatory steps controlling autophagosome formation, including the mechanisms of phospholipid transfer across membrane contact sites. The project deliverables will include development of a general, quantitative, and predictive model of autophagosome biogenesis during non-selective autophagy, with findings applicable to understanding how cells regulate the number, size, duration, and substrate scope of autophagosomes in response to intracellular and environmental challenges. These research outcomes are intended to advance foundational knowledge with broad implications for human disease prevention and treatment across multiple disease areas.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $404.9k | 5/26/26 |